Monopar Therapeutics Inc. · NASDAQ:MNPR
Cittadine Andrew exercised options for 3,514 Monopar Therapeutics Inc. shares (Form 4)
Traded Mar 31, 2026 · Filed Apr 2, 2026
On Mar 31, 2026, Cittadine Andrew (Chief Operating Officer) exercised options for 3,514 Monopar Therapeutics Inc. shares, leaving 52,669 shares. Filed Apr 2, 2026 (Form 4).
- Options exercised
- 3,514 shares
- Holding after
- 52,669 shares
- Trading plan
- No
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | Option exercise | 3,514 | 54,240 | Direct | |
| Mar 31, 2026 | Common Stock | Shares withheld for tax | 1,571 | US$54.79 | 52,669 | Direct |
Source
Related
- Monopar Therapeutics Inc.
- Cittadine Andrew
- Monopar Therapeutics Inc. shareholders
- Form 4 · Cittadine Andrew · Oct 2, 2026
- Form 4 · Cittadine Andrew · Jul 2, 2026
- Form 4 · Robinson Chandler · Oct 20, 2026
- Form 4 · Starr Christopher M · Oct 5, 2026
- Form 4 · Vu Quan Anh · Oct 2, 2026
- Form 4 · Robinson Chandler · Oct 2, 2026
- Form 4 · Robinson Chandler · Sep 28, 2026